Remdesivir, which is manufactured by pharma giant Gilead Sciences has been hailed as the frontrunner in the treatment of novel coronavirus, as scientists and medical researchers race against time to find a potential cure or vaccine for the same.
In a statement, the Drugs Controller General of India said, “(Remdesivir) approved on June 1 under emergency use with the condition for five dose administration,”
